Business / Industry Sectors
Life Sciences & Pharmaceutical > Biotechnology
Oramed Pharmaceuticals
Oramed
Oramed Pharmaceuticals (NASDAQCM:ORMP) is developing proprietary Protein Oral Delivery (PODâ„¢) technology for the delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently approaching a Phase 2b multi-center trial under the USFDA, the Company is seeking to revolutionize the treatment of diabetes.
Contact Information
Ariella Nachman
Phone no.: 972-2-566-0001
ad
ad
ad
ad
ad
ad